Novartis
NVS
NVS
1,340 hedge funds and large institutions have $15.4B invested in Novartis in 2025 Q1 according to their latest regulatory filings, with 121 funds opening new positions, 425 increasing their positions, 501 reducing their positions, and 79 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
0.63% more ownership
Funds ownership: 5.95% → 6.58% (+0.63%)
12% less call options, than puts
Call options by funds: $246M | Put options by funds: $281M
15% less repeat investments, than reductions
Existing positions increased: 425 | Existing positions reduced: 501
Holders
1,340
Holding in Top 10
14
Calls
$246M
Puts
$281M
Top Buyers
| 1 | +$531M | |
| 2 | +$202M | |
| 3 | +$154M | |
| 4 |
Marshall Wace
London,
United Kingdom
|
+$150M |
| 5 |
Point72 Asset Management
Stamford,
Connecticut
|
+$121M |
Top Sellers
| 1 | -$88.3M | |
| 2 | -$73.2M | |
| 3 | -$71.6M | |
| 4 |
Qube Research & Technologies (QRT)
London,
United Kingdom
|
-$66.3M |
| 5 |
D.E. Shaw & Co
New York
|
-$64.3M |
